Risk of lowering mortality from the improvement of inflammatory markers and disease progression among moderate, severe, and critical COVID-19 patients using anticoagulant : a cross-sectional study from two second referral hospitals in Surabaya, Indonesia
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.